Stockreport

Incyte, Novartis launch drug study to treat coronavirus complication [MarketWatch]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a serious complication of COVID-19. The biotech company sa [Read more]